Prescription opioids have already been a salient issue in the medical world. Patients have misused the drugs for anxiety issues and recreational use. The FDA recently approved a new opioid analgesic, and many heath care, consumer and addiction drugs are concerned.
The federal agency approves a new therapy Myalept (metreleptin for injection) as a replacement therapy to treat complications associated with deficiency of leptin, in addition to diet, for those battling with congenital or acquired generalized lipodystrophy.
In a latest announcement, the U.S. Food and Drug Administration issued first order to halt the sale and distribution of four tobacco products.
Chelsea Therapeutics announces the U.S. Food and Drug Administration’s acceptance for the new drug Northera capsules to treat a rare form of low blood pressure disorder.
The California based BioMarin Pharmaceutical off lately announced that the U.S. Food and Drug Administration cleared its new drug Vimizim to treat a rare genetic disorder ‘Mroquio A syndrome’.
Researchers may have stumbled across a new tool to make colonoscopies less uncomfortable. At this time, inserting a long, thin and flexible tube into the colon is the only way to detect the possibility of ulcers, colon polyps, tumors or any areas of inflammation that could cause bleeding in the rect...
A new drug Hetlioz receives a nod from the U.S. Food and Drug Administration to treat sleep disorder in the totally blind individuals. This is the first drug approved by FDA to treat the non-24 hour sleep wake disorder.
The medical technology company Affymetrix Inc. has just received approval from the U.S. Food and Drug Administration to market its procedure in order to help diagnose disabilities in children.
A potential medication for treating multiple sclerosis (MS) has failed to gain U.S. approval, according to the U.S. Food and Drug Administration (FDA).
As of Monday, an advisory panel of medical experts voted to recommend the approval of a drug for both ulcerative colitis and Crohn's disease developed by Takeda Pharmaceutical Co.
The Food and Drug Administration (FDA) approved three new personalized vaccines designed for children and elderly people.
The U.S. Food and Drug Administration has recently approved the first adjuvanted vaccine for H5N1 influenza, or what's already known as the avian or bird flu. However, this vaccine won't be available for commercial use and does not currently have a trade name in the United States, according to a pre...